Nelarabine Injection, Solution
Product Images NDC 25021-259

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 25021-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nel03 0000 01)

Chemical structure of the active ingredient Nelarabine, showing its molecular formula with nitrogen, oxygen, and carbon atoms arranged in a complex ring and sugar moiety typical of a nucleoside analogue.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Nel03 0000 02)

Nelarabine Injection 250 mg per 50 mL (5 mg per mL) in a 50 mL single-dose vial, labeled for intravenous infusion only. The sterile, preservative-free solution is produced by Sagent Pharmaceuticals, with manufacturing information and storage instructions on the label. The label includes caution for cytotoxic agent handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.